The outlook remains stable.
The “Ba1” rating affirmation and maintenance of the stable outlook reflects Palomar Health’s improved operating performance and growing cash measures.
Moody’s also affirmed the “Ba1” rating on Palomar Health’s parity revenue bonds worth $550 million.
More articles on healthcare finance:
Consumer-facing app combs medical bills for mistakes
Moody’s assigns ‘P-1’ rating to Northwestern Memorial HealthCare’s notes
Parasail Health partners with medical debt settlement platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
